Menveo
NDC 58160-827, Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, injection, solution, from GlaxoSmithKline Biologicals SA.
- Product NDC
- 58160-827
- Status
- Listed
- Labeler
- GlaxoSmithKline Biologicals SA
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125300
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58160-827 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN10 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN5 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN5 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP Y CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN5 ug/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Inactivated Meningococcal Vaccine [EPC]; Inactivated Meningococcal Vaccine [EPC]; Inactivated Meningococcal Vaccine [EPC]; Inactivated Meningococcal Vaccine [EPC]; Meningococcal Vaccines [CS]; Meningococcal Vaccines [CS]; Meningococcal Vaccines [CS]; Meningococcal Vaccines [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58160-827-30 | 58160082730 | 10 VIAL in 1 CARTON (58160-827-30) / .5 mL in 1 VIAL (58160-827-03) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58160-827 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58160-827 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58160-827. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.